21043 results
-
List item
Human medicine European public assessment report (EPAR): Ryeqo (updated)
relugolix, norethisterone acetate, estradiol hemihydrate, Leiomyoma
Date of authorisation: 16/07/2021,
, Revision: 6, Authorised, Last updated: 04/12/2023
-
List item
Human medicine European public assessment report (EPAR): Yesafili (updated)
aflibercept, Macular Edema; Retinal Vein Occlusion; Diabetic Retinopathy; Myopia, Degenerative; Diabetes Complications
Date of authorisation: 15/09/2023,, 
, Revision: 1, Authorised, Last updated: 04/12/2023
-
List item
Human medicine European public assessment report (EPAR): Leflunomide medac (updated)
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 27/07/2010,
, Revision: 19, Authorised, Last updated: 04/12/2023
-
List item
Human medicine European public assessment report (EPAR): Filgrastim Hexal (updated)
filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 06/02/2009,, Revision: 24, Authorised, Last updated: 04/12/2023
-
List item
Human medicine European public assessment report (EPAR): Opzelura (updated)
ruxolitinib phosphate, Vitiligo
Date of authorisation: 19/04/2023, Revision: 2, Authorised, Last updated: 04/12/2023 -
List item
Human medicine European public assessment report (EPAR): Ziextenzo (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 22/11/2018,, Revision: 9, Authorised, Last updated: 04/12/2023
-
List item
Human medicine European public assessment report (EPAR): Qutenza (updated)
capsaicin, Neuralgia
Date of authorisation: 15/05/2009, Revision: 19, Authorised, Last updated: 04/12/2023 -
List item
Human medicine European public assessment report (EPAR): Levitra (updated)
vardenafil, Erectile Dysfunction
Date of authorisation: 06/03/2003, Revision: 33, Authorised, Last updated: 04/12/2023 -
List item
Human medicine European public assessment report (EPAR): Rilutek (updated)
Riluzole, Amyotrophic Lateral Sclerosis
Date of authorisation: 10/06/1996, Revision: 32, Authorised, Last updated: 04/12/2023 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)
clopidogrel (as hydrochloride), Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 19, Authorised, Last updated: 04/12/2023
-
List item
Human medicine European public assessment report (EPAR): Hycamtin (updated)
topotecan, Ovarian Neoplasms; Uterine Cervical Neoplasms; Small Cell Lung Carcinoma
Date of authorisation: 12/11/1996, Revision: 39, Authorised, Last updated: 04/12/2023 -
List item
Human medicine European public assessment report (EPAR): Pylobactell (updated)
urea (13C), Breath Tests; Helicobacter Infections
Date of authorisation: 07/05/1998, Revision: 12, Authorised, Last updated: 04/12/2023 -
List item
Human medicine European public assessment report (EPAR): Fulphila (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, Revision: 12, Authorised, Last updated: 04/12/2023
-
List item
Human medicine European public assessment report (EPAR): Orladeyo (updated)
berotralstat dihydrochloride, Angioedemas, Hereditary
Date of authorisation: 30/04/2021, Revision: 5, Authorised, Last updated: 01/12/2023 -
List item
Human medicine European public assessment report (EPAR): Semglee (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 23/03/2018,, Revision: 10, Authorised, Last updated: 01/12/2023
-
List item
Human medicine European public assessment report (EPAR): Ogivri (updated)
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 12/12/2018,, Revision: 11, Authorised, Last updated: 01/12/2023
-
List item
Human medicine European public assessment report (EPAR): Kirsty (previously Kixelle) (updated)
insulin aspart, Diabetes Mellitus
Date of authorisation: 05/02/2021,, , Revision: 4, Authorised, Last updated: 01/12/2023
-
List item
Human medicine European public assessment report (EPAR): Hulio (updated)
adalimumab, Hidradenitis Suppurativa; Psoriasis; Uveitis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Crohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic
Date of authorisation: 17/09/2018,, Revision: 16, Authorised, Last updated: 01/12/2023
-
List item
Human medicine European public assessment report (EPAR): Dovprela (previously Pretomanid FGK) (updated)
Pretomanid, Tuberculosis, Multidrug-Resistant
Date of authorisation: 31/07/2020,, 
, Revision: 9, Authorised, Last updated: 01/12/2023
-
List item
Human medicine European public assessment report (EPAR): Adcetris (updated)
Brentuximab vedotin, Lymphoma, Non-Hodgkin; Hodgkin Disease
Date of authorisation: 25/10/2012,, Revision: 35, Authorised, Last updated: 01/12/2023
-
List item
Human medicine European public assessment report (EPAR): Otezla (updated)
apremilast, Arthritis, Psoriatic; Psoriasis
Date of authorisation: 15/01/2015, Revision: 21, Authorised, Last updated: 01/12/2023 -
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine (inactivated, adjuvanted) Valneva (updated)
COVID-19 vaccine (inactivated, adjuvanted, adsorbed), COVID-19 virus infection
Date of authorisation: 24/06/2022, Revision: 6, Withdrawn, Last updated: 01/12/2023 -
List item
Human medicine European public assessment report (EPAR): Plavix (updated)
clopidogrel hydrogen sulfate, Stroke; Peripheral Vascular Diseases; Atrial Fibrillation; Myocardial Infarction; Acute Coronary Syndrome
Date of authorisation: 15/07/1998, Revision: 50, Authorised, Last updated: 01/12/2023 -
List item
Human medicine European public assessment report (EPAR): Cialis (updated)
tadalafil, Erectile Dysfunction
Date of authorisation: 12/11/2002, Revision: 32, Authorised, Last updated: 01/12/2023 -
List item
Human medicine European public assessment report (EPAR): Ozawade (updated)
pitolisant, Sleep Apnea, Obstructive
Date of authorisation: 01/09/2021, Revision: 3, Authorised, Last updated: 01/12/2023